Dr. Nick Terrafranca explains in detail the many facets involved in the commercialization process of a given therapy. Dr Terrafranca is the CEO of NeuroRecovery Technologies, the start-up working with Prof Reggie Edgerton to commercialise Prof Edgerton’s spinal neurostimulation breakthrough.
Videos
UTSpeaks – Reviving Reasons to Hope
For people living with the devastating effects of spinal cord injury or failing brain function, recovery has remained doubtful. But startling US research advances are now seeing movement and feeling restored to people with spinal cord injury. UTS will build…
Prof V. Reggie Edgerton lecture on neuromodulation research
Professor Edgerton discusses his research in neuromodulation to treat chronic spinal cord injury and details the extraordinary results being achieved. Professor Edgerton visited Australia as a guest of SpinalCure and the University of Technology Sydney. Thanks to Royal Rehab for…
Dr Robert Langer explains polymer scaffold/neural stem cell combo for SCI
ISSCR 2015: Dr Stephen Huhn presents update on StemCells Inc's progress
What is a neural stem cell?
https://vimeo.com/118301922 Everything you always wanted to know about neural stem cells in just over 1 minute CREDITS Narration by: Dr. Sam Weiss Written & Directed by: Ben Paylor & Mike Long Produced by: Infoshots – infoshots.ca Animation by: David Murawsky…
New flexible implant for electrical stimulation of spinal cord
Professors Stéphanie Lacour and Grégoire Courtine have developed e-Dura, a flexible stretchy implant designed specifically for implantation on the surface of the brain or spinal cord. The small device closely imitates the mechanical properties of living tissue, and can simultaneously deliver…
Latest on clinical trials for SCI in Japan
http://vimeo.com/114285582 Dr. Masatoshi Ito, Executive Director of the Japan SCI Foundation recently gave an update of the clinical trial progress in Japan at Working 2 Walk 2014 hosted by Unite 2 Fight Paralysis. “Current SCI clinical studies in Japan include…
Restoration of function after spinal cord injury
Modulation of CSPG receptor promotes locomotor and urinary recovery (video)
Dr. Silver presents findings from his lab’s discovery that peptide modulation of the CSPG receptor PTP allowed for remarkable recovery of hindlimb function, locomotor activity, and bladder control in 17 of 20 animals. Thanks to Unite 2 Fight Paralysis